Glycoprotein IIb/IIIa inhibitors: Do they still have a role?

Journal of the American College of Cardiology

Volumn 57, Issue 10, 2011, Pages 1200-1201

  Bhatt, Deepak L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; BLEEDING; DRUG FATALITY; EDITORIAL; HEART INFARCTION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; STROKE; THROMBOCYTOPENIA;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; HIRUDINS; HUMANS; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT PROTEINS;

EID: 79952288998     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.10.031     Document Type: Editorial

References (20)

1. D.L. Bhatt, and E.J. Topol Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes JAMA 284 2000 1549 1558
2. D.L. Bhatt, S.P. Marso, A.M. Lincoff, K.E. Wolski, S.G. Ellis, and E.J. Topol Abciximab reduces mortality in diabetics following percutaneous coronary intervention J Am Coll Cardiol 35 2000 922 928 (Pubitemid 30189923)
3. D.E. Winchester, X. Wen, W.D. Brearley, K.E. Park, R.D. Anderson, and A.A. Bavry Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines J Am Coll Cardiol 57 2011 1190 1199
4. D.L. Bhatt, and E.J. Topol Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes Circulation 112 2005 906 915 discussion 923
5. D.L. Bhatt, A.M. Lincoff, and C.M. Gibson Intravenous platelet blockade with cangrelor during PCI N Engl J Med 361 2009 2330 2341
6. R.A. Harrington, G.W. Stone, and S. McNulty Platelet inhibition with cangrelor in patients undergoing PCI N Engl J Med 361 2009 2318 2329
7. A. Bellemain-Appaix, D. Brieger, and F. Beygui New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis J Am Coll Cardiol 56 2010 1542 1551
8. A.W. Chan, D.L. Bhatt, and D.P. Chew Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696 (Pubitemid 34157371)
9. A.W. Chan, D.L. Bhatt, and D.P. Chew Relation of inflammation and benefit of statins after percutaneous coronary interventions Circulation 107 2003 1750 1756 (Pubitemid 36418355)
10. S.P. Marso, A.P. Amin, and J.A. House Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention JAMA 303 2010 2156 2164
11. D.L. Bhatt Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not JAMA 303 2010 2188 2189
12. A.M. Lincoff, N.S. Kleiman, and D.J. Kereiakes Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703 (Pubitemid 39062523)
13. G.W. Stone, J.H. Ware, and M.E. Bertrand Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial JAMA 298 2007 2497 2506 (Pubitemid 350223536)
14. G.W. Stone, H.D. White, and E.M. Ohman Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Lancet 369 2007 907 919 (Pubitemid 46400858)
15. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
16. D.P. Chew, D.L. Bhatt, A.M. Lincoff, K. Wolski, and E.J. Topol Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk Heart 92 2006 945 950 (Pubitemid 43974059)
17. R. Mehran, S.J. Pocock, and G.W. Stone Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
18. R. Mehran, A.J. Lansky, and B. Witzenbichler Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
19. A.Y. Fung, J. Saw, and A. Starovoytov Abbreviated infusion of eptifibatide after successful coronary intervention: the BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial J Am Coll Cardiol 53 2009 837 845
20. P.B. Berger, and P.J.M. Best Intracoronary glycoprotein IIb/IIIa inhibitors: from questioning the logic to weighing the data J Am Coll Cardiol Interv 3 2010 935 936